FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037192235> ?p ?o ?g. }

• W3037192235 abstract "Abstract Background The optimal treatment of osteoporosis after reconstruction surgery for osteoporotic vertebral fractures (OVF) remains unclear. In this multicentre retrospective study, we investigated the effects of typically used agents for osteoporosis, namely, bisphosphonates (BP) and teriparatide (TP), on surgical results in patients with osteoporotic vertebral fractures. Methods Retrospectively registered data were collected from 27 universities and affiliated hospitals in Japan. We compared the effects of BP vs TP on postoperative mechanical complication rates, implant-related reoperation rates, and clinical outcomes in patients who underwent posterior instrumented fusion for OVF. Data were analysed according to whether the osteoporosis was primary or glucocorticoid-induced. Results A total of 159 patients who underwent posterior instrumented fusion for OVF were included. The overall mechanical complication rate was significantly lower in the TP group than in the BP group (BP vs TP: 73.1% vs 58.2%, p = 0.045). The screw backout rate was significantly lower and the rates of new vertebral fractures and pseudoarthrosis tended to be lower in the TP group than in the BP group. However, there were no significant differences in lumbar functional scores and visual analogue scale pain scores or in implant-related reoperation rates between the two groups. The incidence of pseudoarthrosis was significantly higher in patients with glucocorticoid-induced osteoporosis (GIOP) than in those with primary osteoporosis; however, the pseudoarthrosis rate was reduced by using TP. The use of TP also tended to reduce the overall mechanical complication rate in both primary osteoporosis and GIOP. Conclusions The overall mechanical complication rate was lower in patients who received TP than in those who received a BP postoperatively, regardless of type of osteoporosis. The incidence of pseudoarthrosis was significantly higher in patients with GIOP, but the use of TP reduced the rate of pseudoarthrosis in GIOP patients. The use of TP was effective to reduce postoperative complications for OVF patients treated with posterior fusion." @default.
• W3037192235 created "2020-07-02" @default.
• W3037192235 creator A5000111717 @default.
• W3037192235 creator A5001669387 @default.
• W3037192235 creator A5002089857 @default.
• W3037192235 creator A5004361310 @default.
• W3037192235 creator A5004438626 @default.
• W3037192235 creator A5005798835 @default.
• W3037192235 creator A5007854558 @default.
• W3037192235 creator A5009341567 @default.
• W3037192235 creator A5011530088 @default.
• W3037192235 creator A5012091563 @default.
• W3037192235 creator A5015073995 @default.
• W3037192235 creator A5015126097 @default.
• W3037192235 creator A5015788559 @default.
• W3037192235 creator A5016159148 @default.
• W3037192235 creator A5018495383 @default.
• W3037192235 creator A5021909976 @default.
• W3037192235 creator A5021933155 @default.
• W3037192235 creator A5022362986 @default.
• W3037192235 creator A5022399260 @default.
• W3037192235 creator A5024382139 @default.
• W3037192235 creator A5024742369 @default.
• W3037192235 creator A5025276777 @default.
• W3037192235 creator A5029316401 @default.
• W3037192235 creator A5029616968 @default.
• W3037192235 creator A5030002198 @default.
• W3037192235 creator A5032413419 @default.
• W3037192235 creator A5032962315 @default.
• W3037192235 creator A5034804236 @default.
• W3037192235 creator A5035062633 @default.
• W3037192235 creator A5039120103 @default.
• W3037192235 creator A5039273068 @default.
• W3037192235 creator A5041320707 @default.
• W3037192235 creator A5041721347 @default.
• W3037192235 creator A5042521889 @default.
• W3037192235 creator A5043056838 @default.
• W3037192235 creator A5044855254 @default.
• W3037192235 creator A5049693558 @default.
• W3037192235 creator A5051090801 @default.
• W3037192235 creator A5051559704 @default.
• W3037192235 creator A5053419815 @default.
• W3037192235 creator A5053597578 @default.
• W3037192235 creator A5053752434 @default.
• W3037192235 creator A5054050845 @default.
• W3037192235 creator A5055163415 @default.
• W3037192235 creator A5056891958 @default.
• W3037192235 creator A5057697851 @default.
• W3037192235 creator A5057882307 @default.
• W3037192235 creator A5057947442 @default.
• W3037192235 creator A5058738322 @default.
• W3037192235 creator A5059595447 @default.
• W3037192235 creator A5059984671 @default.
• W3037192235 creator A5062019634 @default.
• W3037192235 creator A5065059683 @default.
• W3037192235 creator A5065653908 @default.
• W3037192235 creator A5069087930 @default.
• W3037192235 creator A5072421956 @default.
• W3037192235 creator A5073243799 @default.
• W3037192235 creator A5075589110 @default.
• W3037192235 creator A5075603582 @default.
• W3037192235 creator A5077792133 @default.
• W3037192235 creator A5078771553 @default.
• W3037192235 creator A5081393135 @default.
• W3037192235 creator A5082598023 @default.
• W3037192235 creator A5083264708 @default.
• W3037192235 creator A5083776031 @default.
• W3037192235 creator A5084127668 @default.
• W3037192235 creator A5090040212 @default.
• W3037192235 creator A5091358195 @default.
• W3037192235 date "2020-07-01" @default.
• W3037192235 modified "2023-10-01" @default.
• W3037192235 title "Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study" @default.
• W3037192235 cites W1036610077 @default.
• W3037192235 cites W1870151894 @default.
• W3037192235 cites W1992310701 @default.
• W3037192235 cites W2004419003 @default.
• W3037192235 cites W2005922920 @default.
• W3037192235 cites W2015762089 @default.
• W3037192235 cites W2033760895 @default.
• W3037192235 cites W2079218100 @default.
• W3037192235 cites W2103276018 @default.
• W3037192235 cites W2138846733 @default.
• W3037192235 cites W2327489463 @default.
• W3037192235 cites W2327824277 @default.
• W3037192235 cites W2344107695 @default.
• W3037192235 cites W2566233089 @default.
• W3037192235 cites W2580721443 @default.
• W3037192235 cites W2595323993 @default.
• W3037192235 cites W2604346861 @default.
• W3037192235 cites W2728709142 @default.
• W3037192235 cites W2759836747 @default.
• W3037192235 cites W2800067200 @default.
• W3037192235 cites W2801554786 @default.
• W3037192235 cites W2902054815 @default.
• W3037192235 cites W2911573459 @default.
• W3037192235 cites W2913311077 @default.
• W3037192235 cites W2916138442 @default.
• W3037192235 cites W2917781841 @default.
• W3037192235 cites W2924558658 @default.

• next